Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001213900-25-075003
Filing Date
2025-08-12
Accepted
2025-08-12 16:34:21
Documents
68
Period of Report
2025-06-30

Document Format Files

Seq Description Document Type Size
1 QUARTERLY REPORT ea0248823-10q_therape.htm   iXBRL 10-Q 532749
2 CERTIFICATION ea024882301ex31-1_therape.htm EX-31.1 9834
3 CERTIFICATION ea024882301ex31-2_therape.htm EX-31.2 9837
4 CERTIFICATION ea024882301ex32-1_therape.htm EX-32.1 4322
5 CERTIFICATION ea024882301ex32-2_therape.htm EX-32.2 4328
  Complete submission text file 0001213900-25-075003.txt   4261569

Data Files

Seq Description Document Type Size
6 XBRL SCHEMA FILE txmd-20250630.xsd EX-101.SCH 47288
7 XBRL CALCULATION FILE txmd-20250630_cal.xml EX-101.CAL 35593
8 XBRL DEFINITION FILE txmd-20250630_def.xml EX-101.DEF 198263
9 XBRL LABEL FILE txmd-20250630_lab.xml EX-101.LAB 383993
10 XBRL PRESENTATION FILE txmd-20250630_pre.xml EX-101.PRE 217576
70 EXTRACTED XBRL INSTANCE DOCUMENT ea0248823-10q_therape_htm.xml XML 423391
Mailing Address 951 YAMATO ROAD, SUITE 220 BOCA RATON FL 33431
Business Address 951 YAMATO ROAD, SUITE 220 BOCA RATON FL 33431 561-961-1900
TherapeuticsMD, Inc. (Filer) CIK: 0000025743 (see all company filings)

EIN.: 870233535 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-00100 | Film No.: 251207301
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)